Tacrolimus in dermatology

Journal of Cutaneous Medicine and Surgery

Volumn 5, Issue 4, 2001, Pages 329-335

  De Tran, Quang Hieu ^a   Guay, Elizabeth ^a   Chartier, Suzanne ^a   Tousignant, Jacqueline ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; TACROLIMUS;

ALOPECIA; ATOPIC DERMATITIS; BEHCET DISEASE; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; GRAFT REJECTION; HUMAN; LUPUS ERYTHEMATOSUS; NONHUMAN; OINTMENT; PRIORITY JOURNAL; PSORIASIS; PYODERMA GANGRENOSUM; REVIEW; SEZARY SYNDROME; SKIN GRAFT; SKIN PAPILLOMA; T LYMPHOCYTE ACTIVATION;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADULT; ANIMALS; BEHCET SYNDROME; CHILD; CLINICAL TRIALS; CRICETINAE; DERMATITIS, ATOPIC; DERMATITIS, CONTACT; DOUBLE-BLIND METHOD; HAIR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, CUTANEOUS; MICE; PLACEBOS; PSORIASIS; PYODERMA GANGRENOSUM; RANDOMIZED CONTROLLED TRIALS; RATS; SEZARY SYNDROME; SKIN DISEASES; SKIN NEOPLASMS; SKIN TRANSPLANTATION; TACROLIMUS; TIME FACTORS;

EID: 0034849587     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1007/s102270000022     Document Type: Review

References (38)

1. Studies on FK 506 in experimental organ transplantation
2. Topical FK506 - Clinical potential or laboratory curiosity?
3. A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine
4. Kidney transplantation under FK 506
5. The clinical trial of FK 506 as primary and rescue immunosuppression in adult cardiac transplantation
6. A prospective randomized trial of FK 506 versus cyclosporine after human pulmonary transplantation
7. Human islet allotransplantation under FK 506
8. Novel immunosuppressive agent, FK 506. In vitro effects of the cloned T cell activation
9. Mode of action of tacrolimus (FK506): Molecular and cellular mechanisms
10. Anti-inflammatory effect of FK 506 on human skin mast cells
11. Tacrolimus (FK 506) - A new therapeutic agent for severe recalcitrant psoriasis
12. Systemic Tacrolimus (FK 506) is effective for the treatment of psoriasis in a double blind, placebo-controlled study
13. Antioncogene P53 and mitogenic cytokine interleukin-8 aberrantly expressed in psoriatic skin are inversely regulated by the antipsoriatic drug tacrolimus (FK 506)
14. Interleukin-8 stimulates calcium transients and promotes epidermal cell proliferation
15. Role of interleukin-8 receptor in skin
16. Topical FK 506: Suppression of allergic and irritant contact dermatitis in the guinea pig
17. Immunosuppressive macrolides of the type FK 506: A novel class of topical agents for treatment of skin diseases?
18. Tacrolimus ointment for atopic dermatitis
19. Successful treatment of resistant facial lesions of atopic dermatitis with 0, 1% FK ointment
20. A short term trial of tacrolimus ointment for atopic dermatitis
21. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children
22. Treatment of atopic dermatitis: Role of tacrolimus ointment as a topical noncorticosteroidal therapy
23. Topical tacrolimus (FK 506): A new milestone in the management of atopic dermatitis
24. Effects of immunosuppressive peptidyl-propyl cis-trans isomerase (PPIase) inhibitors, cyclosporine A, FK 506, ascomycin and rapamycin on hair growth initiation in mouse: Immunosuppression is not required for new hair growth
25. Stimulation of hair growth by topical application of FK 506, a potent immunosuppressive agent
26. Induction of anagen in telogen mouse skin by topical application of FK 506, a potent immunosuppressant
27. Hair growth modulation by topical immunophilin ligands
28. Rapid hair regrowth in refractory alopecia universalis associated with autoimmune disease following liver transplantation and tacrolimus (FK506) therapy
29. Anti-liver-kidney microsome antibody positive autoimmune hepatitis associated with alopecia
30. Chronic active hepatitis associated with vitiligo, nail dystrophy, alopecia and a new variant of LKM antibodies
31. The use of FK 506 and skin allografting for the treatment of severe burns in an animal model
32. Topical immunosuppression in skin grafting with FK 506 ointment
33. Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum
34. FK 506: Therapeutic effects on lupus dermatoses in autoimmune-prone MRL/Mp-lrp/lpr mice
35. + T cells, cytokine gene expression and disease activity in MRL/MpJ-lpr/lpr mice
36. Anti-tumor-promoting action of FK 506, a potent immunosuppressive agent
37. Abstract 242: A new immunomodulatory agent to treat Sezary's syndrome
38. Pulmonary infiltrates recovered by FK506 in a patient with Behçet's disease